Fused ring dicationic anti-protozoan agents and their prodrugs
US7825279B2 · kind B2 · utility
0Cited by
5References
122Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 18, 2004 |
| Grant date | Nov 2, 2010 |
| Priority date | — |
| Expiry date | Mar 21, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel fused ring dicationic anti-protozoan compounds. Representative protozoan species include but are not limited to Trypanosoma brucei rhodesiense (T.b.r.) and Plasmodium falciparum. Prodrugs of these compounds can be used as an oral treatment for malaria and human African trypanosomiasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.